Unknown

Dataset Information

0

TAK-071, a novel M1 positive allosteric modulator with low cooperativity, improves cognitive function in rodents with few cholinergic side effects.


ABSTRACT: The muscarinic M1 receptor (M1R) is a promising target for treating cognitive impairment associated with cholinergic deficits in disorders such as Alzheimer's disease and schizophrenia. We previously reported that cooperativity (?-value) was key to lowering the risk of diarrhea by M1R positive allosteric modulators (M1 PAMs). Based on this, we discovered a low ?-value M1 PAM, TAK-071 (?-value: 199), and characterized TAK-071 using T-662 as a reference M1 PAM with high ?-value of 1786. Both TAK-071 and T-662 were potent and highly selective M1 PAMs, with inflection points of 2.7 and 0.62?nM, respectively. However, T-662 but not TAK-071 augmented isolated ileum motility. TAK-071 and T-662 increased hippocampal inositol monophosphate production through M1R activation and improved scopolamine-induced cognitive deficits in rats at 0.3 and 0.1?mg/kg, respectively. TAK-071 and T-662 also induced diarrhea at 10 and 0.1?mg/kg, respectively, in rats. Thus, taking into consideration the fourfold lower brain penetration ratio of T-662, TAK-071 had a wider margin between cognitive improvement and diarrhea induction than T-662. Activation of M1R increases neural excitability via membrane depolarization, reduced afterhyperpolarization, and generation of afterdepolarization in prefrontal cortical pyramidal neurons. T-662 induced all three processes, whereas TAK-071 selectively induced afterdepolarization. Combining sub-effective doses of TAK-071, but not T-662, with an acetylcholinesterase inhibitor, significantly ameliorated scopolamine-induced cognitive deficits in rats. TAK-071 may therefore provide therapeutic opportunities for cognitive dysfunction related to cholinergic deficits or reduced M1R expression, while minimizing peripheral cholinergic side effects.

SUBMITTER: Sako Y 

PROVIDER: S-EPMC6461781 | biostudies-literature | 2019 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

TAK-071, a novel M<sub>1</sub> positive allosteric modulator with low cooperativity, improves cognitive function in rodents with few cholinergic side effects.

Sako Yuu Y   Kurimoto Emi E   Mandai Takao T   Suzuki Atsushi A   Tanaka Maiko M   Suzuki Motohisa M   Shimizu Yuji Y   Yamada Masami M   Kimura Haruhide H  

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20180801 5


The muscarinic M<sub>1</sub> receptor (M<sub>1</sub>R) is a promising target for treating cognitive impairment associated with cholinergic deficits in disorders such as Alzheimer's disease and schizophrenia. We previously reported that cooperativity (α-value) was key to lowering the risk of diarrhea by M<sub>1</sub>R positive allosteric modulators (M<sub>1</sub> PAMs). Based on this, we discovered a low α-value M<sub>1</sub> PAM, TAK-071 (α-value: 199), and characterized TAK-071 using T-662 as a  ...[more]

Similar Datasets

| S-EPMC6411103 | biostudies-literature
| S-EPMC9291057 | biostudies-literature
| S-EPMC3794927 | biostudies-literature
| S-EPMC3477233 | biostudies-other
| S-EPMC6986443 | biostudies-literature
| S-EPMC4911410 | biostudies-literature
| S-EPMC2206566 | biostudies-literature
| S-EPMC2575317 | biostudies-other
| S-EPMC6026448 | biostudies-literature
| S-EPMC4281359 | biostudies-literature